Today, Congresswoman Nikki Budzinski (IL-13) hosted a roundtable with independent pharmacists, pharmacy students and faculty ...

Doha Mekki, the No. 2 official in the U.S. Justice Department’s Antitrust Division, said her agency is investigating whether it should take action in the health care space generally, and specifically ...

It remains to be seen how well President Joe Biden’s Inflation Reduction Act will actually work in lowering prescription drug ...

No matter what happens in this election, the government should work for the people. The government may not be perfect, but it ...

Skyrocketing demand for weight loss and diabetes drugs has forced Eli Lilly and Novo Nordisk, to invest billions to increase ...

The owner of one of the three largest pharmacy middlemen in the United States last month filed suit to quash an attempt by the Federal Trade Commission to investigate industry ...

The election could have major impacts on drug prices, Medicaid, the Affordable Care Act, public health agencies, abortion, ...

A drug pricing expert reveals the shocking cost disparity of a life-saving spinal muscular atrophy drug in India, priced at ...

Elizabeth Warren seeks scrutiny of deals that would allow drug middlemen McKesson, Cardinal Health, and Cencora to also ...

The review of Minnesota-based Optum’s business practices by the Mississippi Board of Pharmacy indicated that the company paid independent pharmacies in Mississippi rates lower than chains and ...

Congresswoman Nikki Budzinski (IL-13) will host a roundtable discussion with independent pharmacists on Saturday, November 2, ...

PBMs represent insurers in drug transactions, and they decide which medicines will be covered. And, because just three PBMs control access to about 80% of insured patients, they have enormous ...